Saturday 17 October 2026
Export CAH’s income statement to Excel — free account
Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
254.06
0.35
+0.14%
Follow CAH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.57 | 29.40 | 32.16 | 32.72 |
P/S ratio |
0.16 | 0.20 | 0.20 | 0.22 | |
P/FCF ratio |
8.39 | 8.76 | 11.25 | 12.31 | |
P/Operating CF |
38.39 | 70.70 | 27.24 | 33.13 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.18 | 0.22 | 0.22 | 0.24 | |
EV/EBITDA |
13.00 | 16.03 | 16.88 | 16.84 | |
EV/Operating CF |
8.33 | 8.98 | 10.92 | 11.61 | |
EV/FCF |
9.38 | 9.89 | 12.37 | 13.19 | |
Quick Ratio |
0.46 | 0.38 | 0.42 | 0.43 | |
Current Ratio |
0.96 | 0.91 | 0.91 | 0.88 | |
Net Debt/EBITDA |
4.93 | 6.64 | 6.58 | 4.15 | |
Debt/Assets |
16.35% | 15.54% | 15.73% | 15.51% | |
Debt/Equity |
(3.31) | (3.34) | (3.34) | (3.26) | |
Asset Turnover |
4.77 | 4.66 | 4.71 | 4.61 | |
Operating CF/Net income |
2.16 | 1.47 | 4.57 | 4.25 | |
Capex/Depreciation |
(0.46) | (0.43) | (0.59) | (1.10) | |
Interest Coverage |
8.35 | 8.03 | 5.04 | 9.23 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.38% | 2.39% | 2.71% | 2.62% | |
Intangible Assets out of Total Assets |
0.22 | 0.24 | 0.24 | 0.24 | |
Share Based Compensation of Revenue |
0.15% | 0.13% | 0.21% | 0.09% | |
Graham Net Nets |
(0.52) | (0.44) | (0.43) | (0.38) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
4.24% | 3.40% | 3.11% | 3.06% | |
Free Cash Flow Yield |
11.93% | 11.41% | 8.89% | 8.13% | |
Revenue per Share |
268.95 | 278.08 | 259.32 | 269.80 | |
Operating CF per Share |
4.09 | 2.91 | 7.76 | 7.17 | |
Capex per Share |
(0.45) | (0.42) | (0.62) | (1.12) | |
Free Cash Flow per Share |
3.63 | 2.48 | 7.14 | 6.05 | |
Cash per Share |
19.30 | 11.77 | 16.75 | 20.58 | |
Shareholders Equity per Share |
(11.47) | (11.44) | (11.37) | (11.54) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(11.47) | (11.44) | (11.37) | (11.54) | |
Free Cash Flow |
865.00 | 586.00 | 1,677.00 | 1,428.00 | |
Working Capital |
(1,731.00) | (4,084.00) | (3,925.00) | (5,151.00) | |
Capital Expenditures |
(108.00) | (100.00) | (146.00) | (264.00) | |
Net Current Asset Value |
(19,422.00) | (21,553.00) | (21,297.00) | (21,270.00) | |
EV/EBIT |
17.60 | 21.61 | 23.63 | 23.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
15.73 | 19.15 | 21.48 | 21.46 | |
| Other line items | |||||
Average Receivables |
12,775.50 | 13,015.50 | 13,157.00 | 13,528.50 | |
Average Payables |
33,612.50 | 35,147.00 | 35,323.00 | 36,498.00 | |
Average Inventory |
16,589.00 | 18,510.00 | 17,082.50 | 17,064.00 | |
Average Assets |
49,143.50 | 52,542.50 | 53,280.00 | 55,210.50 | |
Average Common Equity |
(3,003.50) | (2,810.50) | (2,285.00) | (2,679.00) |
Columns are period end dates